| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/07/2012 | US8110399 Isolating nestin-positive stem cells, expanding and translplanting into a patient to replace lost or damaged insulin secreting cells; differentiating pancreatic stem cells to obtain cells that produce insulin and other hormones |
| 02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
| 02/07/2012 | US8110370 IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer |
| 02/07/2012 | US8110367 Methods for diagnosing renal disorders |
| 02/07/2012 | US8110204 Method of treating human-immunodeficiency virus (HIV) disease infection |
| 02/07/2012 | US8110203 Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes |
| 02/07/2012 | US8110196 Methods and compositions for polytopic vaccination |
| 02/07/2012 | US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders |
| 02/07/2012 | US8110188 Compositions for prevention and treatment of infections caused by coccidia in chickens |
| 02/07/2012 | US8110180 Method of use of cytokine ZALPHA11 ligand |
| 02/07/2012 | US8110177 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| 02/07/2012 | US8109967 High strength suture with absorbable core and suture anchor combination |
| 02/07/2012 | CA2510006C Compositions comprising a combination of diphenyl urea impdh inhibitors and apoptosis-inducing anti-cancer agents |
| 02/07/2012 | CA2486144C Compositions comprising an angiotensin receptor blocker, a calcium channel blocker and a diuretic |
| 02/07/2012 | CA2465906C Method and apparatus for the stimulation of hair growth |
| 02/07/2012 | CA2431669C Pesticidal and antiparasitic compositions comprising chitinase or chitin and sulfide |
| 02/07/2012 | CA2385312C Compositions and methods for preventing and treating transplant rejection |
| 02/07/2012 | CA2333147C Cancer treatment methods using antibodies to aminophospholipids |
| 02/02/2012 | WO2012015027A1 Therapeutic agent or prophylactic agent for neuropathic pain |
| 02/02/2012 | WO2012014238A1 Composition for the treatment and prevention of herpes simplex labialis |
| 02/02/2012 | WO2012013791A1 Compositions for treating heartworm infestation |
| 02/02/2012 | WO2011069484A3 Dermal, antimicrobial foot cream |
| 02/02/2012 | US20120029475 Drug Combinations Useful for Prevention of Restenosis |
| 02/02/2012 | US20120029082 Nutritional or therapeutic compositions to increase bodily glutathione levels |
| 02/02/2012 | US20120029079 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids |
| 02/02/2012 | US20120027755 Prevention and treatment of alzheimer's disease |
| 02/02/2012 | US20120027751 Antagonists of tweak and of tweak receptor and their use to treat immunological disorders |
| 02/02/2012 | US20120027744 Modified heparinase iii and methods of sequencing therewith |
| 02/02/2012 | US20120027706 Methods for treating skin pigmentation |
| 02/02/2012 | DE102010032482A1 New receptor agonist having renin-suppressing activity, antihypertrophic activity and influence of second messenger cyclic guanosine monophosphate during vasodilation, natriuresis and diuresis, useful to treat e.g. nephrotic syndrome |
| 02/02/2012 | CA2807084A1 Preservative free brimonidine and timolol solutions |
| 02/02/2012 | CA2807081A1 Preservative free bimatoprost and timolol solutions |
| 02/02/2012 | CA2806153A1 Compositions for treating heartworm infestation |
| 02/02/2012 | CA2805371A1 Therapeutic agent or prophylactic agent for neuropathic pain |
| 02/01/2012 | EP2412374A1 Pharmaceutical composition for enhancing adiponectin production and food useful therefor |
| 02/01/2012 | EP2412368A1 Method and composition for the treatment of scars |
| 02/01/2012 | EP2411521A1 Compositions for stimulation of mammalian innate immune resistance to pathogens |
| 02/01/2012 | EP2411087A1 Binary and tertiary galvanic particulates and methods of manufacturing and use thereof |
| 02/01/2012 | EP2411020A2 Compositions and methods for treatment of hemorrhage |
| 02/01/2012 | EP2411001A1 P2x3, receptor antagonists for treatment of pain |
| 02/01/2012 | EP2410987A1 Methods of treatment using combination therapy |
| 02/01/2012 | EP2410859A1 Transdermal delivery |
| 02/01/2012 | EP2410857A1 P2x3, receptor antagonists for treatment of pain |
| 02/01/2012 | EP2037925B1 Combinations comprising 5ht6 modulators and cholinesterase inhibitors |
| 02/01/2012 | EP1425390B1 Materials and methods to promote repair of nerve tissue |
| 02/01/2012 | EP1353699B1 Beta-cyclodextrin-drospirenone inclusion complexes |
| 02/01/2012 | CN1755368B 精子膜表面麦芽凝集素受体定量检测试剂、试剂盒 Sperm membrane surface lectin receptors malt quantitative detection reagents, kits |
| 02/01/2012 | CN1742731B 治疗雌性性机能障碍的吡唑并嘧啶酮类 Treatment of female sexual dysfunction Pyrazolopyrimidine ketones |
| 02/01/2012 | CN102341124A External preparation containing analgesic/anti-inflammatory agent |
| 02/01/2012 | CN102341123A External preparation containing analgesic/anti-inflammatory agent |
| 02/01/2012 | CN102341122A External preparation containing analgesic/anti-inflammatory agent |
| 02/01/2012 | CN102341110A Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
| 02/01/2012 | CN102341107A Combination therapies for neoplastic disorders |
| 02/01/2012 | CN102337268A Human CTRP4 gene, its coding protein and their application |
| 02/01/2012 | CN102336833A CHD1L-TCTP binding blocking agent as well as medical combination with same and application thereof |
| 02/01/2012 | CN102336758A Compound and combination as HCV polymerase inhibitors |
| 02/01/2012 | CN102336716A 嘧啶衍生物 Pyrimidine derivatives |
| 02/01/2012 | CN102335435A Multifunctional polyurethane medicament carrier as well as preparation method and application thereof |
| 02/01/2012 | CN102335430A Compound pharmaceutical composition containing midazolam and neuro protective agent |
| 02/01/2012 | CN102335429A Tumor inhibiting medicine composition and purpose thereof |
| 02/01/2012 | CN102335173A Polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione |
| 02/01/2012 | CN102335121A Preparation and application of pH sensitive in situ gel for vagina |
| 02/01/2012 | CN102334561A Stable oil product, manufacturing method thereof and method for improving survival of strains of lactobacillus |
| 02/01/2012 | CN101816663B 治疗家畜弓形虫病的药物组合物、注射液及其制备方法 Treatment of livestock toxoplasmosis pharmaceutical compositions injection and preparation method |
| 02/01/2012 | CN101439182B 一种生长抑素受体介导的肿瘤靶向药物组合物 One kind of somatostatin receptor-mediated tumor targeting pharmaceutical composition |
| 02/01/2012 | CN101247795B 用于治疗与中枢神经系统（cns）相关疾病的方法和组合物 A method for the treatment of central nervous system (cns) related diseases and compositions |
| 01/31/2012 | US8106099 2'-{[2-(4-methoxyphenyl)acetylamino]methyl}biphenyl-2-carboxylic acid (2-pyridin-3-ylethyl)amide or other phenylcarboxamide derivatives with dofetilide, ibutilide, almokalant, sotalol, azimilide, amiodarone, E4031, clofilium, ambasilide, MS551, tedisamil, bertosamil and quinidine as IKr chahel blocker |
| 01/31/2012 | US8106041 Combination product comprising an antagonist or inverse agonist of histamine receptor H3 and an antipsychotic and antidepressant agent, and use thereof for the preparation of a medicament that prevents the adverse effects of psychotropic drugs |
| 01/31/2012 | US8105774 Using peroxisome proliferator-activated receptor gamma, coactivator 1 beta (PGC-1Beta) as tool to identify modulators for treatment of free radical associated disorders |
| 01/31/2012 | US8105631 Opioid agonist/antagonist combinations |
| 01/31/2012 | US8105608 Method of treatment using ligand-immunogen conjugates |
| 01/31/2012 | US8105599 Administering a compound which binds to a C-type lectin on the surface of a dendritic cell, with the proviso that the C-type lectin is not the DEC-205 receptor |
| 01/31/2012 | US8105580 Methods of using adipose derived stem cells to promote wound healing |
| 01/31/2012 | US8104482 Method for treating a thrombosis |
| 01/31/2012 | CA2508022C Mastitis treatment |
| 01/31/2012 | CA2496897C Methods and compositions for modulating xbp-1 activity |
| 01/31/2012 | CA2493023C Use of alkylphosphocholines in combination with antitumor medicaments |
| 01/31/2012 | CA2394938C Glyoxalase i for reducing carbonyl compounds in carbonyl stress |
| 01/31/2012 | CA2380216C Use of interleukin-18 inhibitors to inhibit tumor metastasis |
| 01/26/2012 | WO2012012627A1 Method of preventing or treating viral infection |
| 01/26/2012 | WO2012012498A2 Use of trp channel agonists to treat infections |
| 01/26/2012 | WO2012012375A1 Composition for retarding and ameliorating photo induced retinal damage and cataracts while ameliorating dry eye syndrome using omega choline |
| 01/26/2012 | WO2012012264A1 Methods and compositions for the treatment of allergy |
| 01/26/2012 | WO2012011174A1 Lipid metabolism improving agent, agent for enhancing lipid metabolism improving action, anti-obesity agent, and agent for enhancing anti-obesity action |
| 01/26/2012 | WO2012010854A1 Inhalation formulations comprising carmoterol in combination with a corticosteroid |
| 01/26/2012 | WO2012010415A1 Pharmaceutical composition containing a tryptophan derivative |
| 01/26/2012 | WO2011151786A3 Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer |
| 01/26/2012 | US20120022268 New Salt Hydrates |
| 01/26/2012 | US20120022165 Transdermal compositions |
| 01/26/2012 | US20120022034 Methods for reducing or neovascularization or edema |
| 01/26/2012 | US20120021997 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 01/26/2012 | US20120021996 Using heat shock proteins to improve the therapeutic benefit of a non-vaccine treatment modality |
| 01/26/2012 | US20120021073 Systemic administration of nac as an adjunct in the treatment of bioterror exposures such as smallpox and use in combination with dhea for the treatment of smallpox |
| 01/26/2012 | US20120021026 Dissolvable Fibrous Web Structure Article Comprising Active Agents |
| 01/26/2012 | CA2805968A1 Pharmaceutical composition containing a tryptophan derivative |
| 01/25/2012 | EP2409705A1 Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells or angiogenesis |
| 01/25/2012 | EP2409703A1 Treatment with alpha7-selective ligands |
| 01/25/2012 | EP2409152A1 Methods for modulating circadian rythms |
| 01/25/2012 | EP2408774A2 Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof |
| 01/25/2012 | EP2408479A1 Combination cancer therapy comprising administration of an egfr inhibitor and an igf-1r inhibitor |